Literature DB >> 20423336

Mitochondria as pharmacological targets.

S Moncada1.   

Abstract

In the last decade, mitochondria have provided a vast area of research for the pharmacologist, with a wealth of potential targets for drug action. Correct target identification and subsequent pharmacological manipulation might greatly help in the prevention and/or treatment of a number of the most prevalent diseases of our time including cancer, neurodegenerative disease and myocardial infarction. This is a commentary to accompany the publication of three papers in this issue of the BJP by Kurz et al., Pravdic et al. and Puerta et al. on different aspects of pharmacology involving mitochondria.

Entities:  

Mesh:

Year:  2010        PMID: 20423336      PMCID: PMC2874844          DOI: 10.1111/j.1476-5381.2010.00706.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  14 in total

Review 1.  Does nitric oxide modulate mitochondrial energy generation and apoptosis?

Authors:  Salvador Moncada; Jorge D Erusalimsky
Journal:  Nat Rev Mol Cell Biol       Date:  2002-03       Impact factor: 94.444

Review 2.  Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms.

Authors:  Eugenia E Calle; Rudolf Kaaks
Journal:  Nat Rev Cancer       Date:  2004-08       Impact factor: 60.716

Review 3.  The organization and inheritance of the mitochondrial genome.

Authors:  Xin Jie Chen; Ronald A Butow
Journal:  Nat Rev Genet       Date:  2005-11       Impact factor: 53.242

Review 4.  Defective mitochondrial biogenesis: a hallmark of the high cardiovascular risk in the metabolic syndrome?

Authors:  Enzo Nisoli; Emilio Clementi; Michele O Carruba; Salvador Moncada
Journal:  Circ Res       Date:  2007-03-30       Impact factor: 17.367

Review 5.  Mitochondria and apoptosis.

Authors:  D R Green; J C Reed
Journal:  Science       Date:  1998-08-28       Impact factor: 47.728

6.  The metabolic enhancer piracetam ameliorates the impairment of mitochondrial function and neurite outgrowth induced by beta-amyloid peptide.

Authors:  C Kurz; I Ungerer; U Lipka; S Kirr; T Schütt; A Eckert; K Leuner; W E Müller
Journal:  Br J Pharmacol       Date:  2010-03-09       Impact factor: 8.739

7.  Methylenedioxymethamphetamine inhibits mitochondrial complex I activity in mice: a possible mechanism underlying neurotoxicity.

Authors:  Elena Puerta; Isabel Hervias; Beatriz Goñi-Allo; Steven F Zhang; Joaquín Jordán; Anatoly A Starkov; Norberto Aguirre
Journal:  Br J Pharmacol       Date:  2010-05       Impact factor: 8.739

8.  Isoflurane protects cardiomyocytes and mitochondria by immediate and cytosol-independent action at reperfusion.

Authors:  D Pravdic; Y Mio; F Sedlic; P F Pratt; D C Warltier; Z J Bosnjak; M Bienengraeber
Journal:  Br J Pharmacol       Date:  2010-05       Impact factor: 8.739

Review 9.  Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia.

Authors:  Robert D Guzy; Paul T Schumacker
Journal:  Exp Physiol       Date:  2006-07-20       Impact factor: 2.969

Review 10.  Mitochondrial free radical generation, oxidative stress, and aging.

Authors:  E Cadenas; K J Davies
Journal:  Free Radic Biol Med       Date:  2000-08       Impact factor: 7.376

View more
  4 in total

1.  Mitochondrial pathway mediates the antileukemic effects of Hemidesmus indicus, a promising botanical drug.

Authors:  Carmela Fimognari; Monia Lenzi; Lorenzo Ferruzzi; Eleonora Turrini; Paolo Scartezzini; Ferruccio Poli; Roberto Gotti; Alessandra Guerrini; Giovanni Carulli; Virginia Ottaviano; Giorgio Cantelli-Forti; Patrizia Hrelia
Journal:  PLoS One       Date:  2011-06-28       Impact factor: 3.240

2.  Mitochondrial Respiratory Complexes as Targets of Drugs: The PPAR Agonist Example.

Authors:  Patrizia Bottoni; Alessandro Pontoglio; Salvatore Scarà; Luisa Pieroni; Andrea Urbani; Roberto Scatena
Journal:  Cells       Date:  2022-03-30       Impact factor: 6.600

Review 3.  Dipeptidyl peptidase-4 inhibitors as new tools for cardioprotection.

Authors:  Marina Rankovic; Nevena Jeremic; Ivan Srejovic; Katarina Radonjic; Aleksandra Stojanovic; Milos Glisic; Stefani Bolevich; Sergey Bolevich; Vladimir Jakovljevic
Journal:  Heart Fail Rev       Date:  2021-03       Impact factor: 4.214

4.  In Vitro Study of the Cytotoxic, Cytostatic, and Antigenotoxic Profile of Hemidesmus indicus (L.) R.Br. (Apocynaceae) Crude Drug Extract on T Lymphoblastic Cells.

Authors:  Eleonora Turrini; Cinzia Calcabrini; Massimo Tacchini; Thomas Efferth; Gianni Sacchetti; Alessandra Guerrini; Guglielmo Paganetto; Elena Catanzaro; Giulia Greco; Carmela Fimognari
Journal:  Toxins (Basel)       Date:  2018-02-06       Impact factor: 4.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.